Anupam Rasayan India reported 37.11% decline in consolidated net profit to Rs 30.62 crore on 25.04% fall in revenue from operations to Rs 293.96 crore in Q2 FY25 over Q2 FY24.

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Onyx Biotec Ltd. (OBL), a pharmaceutical company specializing in sterile water for injections, is making its debut on the ...

The report shows strong growth in Asian markets, with India at 8.8% CAGR, followed by China (8.7%) and South Korea (8.6%).

Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear ...

The event organised by Informa Markets in India, will be one-stop destination for innovative, cost-effective solutions for ...

The latest GDP figures come as a blow to Rachel Reeves, the chancellor, who said she was not "satisfied with the numbers".

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

The main UK stock indexes were subdued on Friday, with losses in AstraZeneca and GSK weighing on the blue-chip FTSE 100, ...

Tarsus Pharmaceuticals (TARS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

The American Petroleum Institute (API) has presented a comprehensive policy roadmap with the goal of securing American energy ...